NSAID-Associated Adverse Effects and Acid Control Aids to Prevent Them
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 29 (2) , 119-132
- https://doi.org/10.2165/00002018-200629020-00002
Abstract
NSAIDs are central to the clinical management of a wide range of conditions. However, NSAIDs in combination with gastric acid, which has been shown to play a central role in upper gastrointestinal (GI) events, can damage the gastroduodenal mucosa and result in dyspeptic symptoms and peptic lesions such as ulceration.Keywords
This publication has 99 references indexed in Scilit:
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac SurgeryNew England Journal of Medicine, 2005
- Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs*Current Medical Research and Opinion, 2004
- Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritisAlimentary Pharmacology & Therapeutics, 2004
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Prevention of the Gastrointestinal Adverse Effects of Nonsteroidal Anti-Inflammatory DrugsDrug Safety, 1999
- Toxicity of Nonsteroidal Anti-Inflammatory DrugsDrugs, 1993
- Cost of treating arthritis and NSAID‐related gastrointestinal side‐effectsAlimentary Pharmacology & Therapeutics, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986